川投能源(600674.SH):兩河口水電站第五台機組正式投產發電
格隆匯12月23日丨川投能源(600674.SH)公佈,公司於2021年12月23日收到持股48%的雅礱江流域水電開發有限公司報吿:雅礱江兩河口水電站第五台機組於2021年12月22日正式投產發電。
兩河口水電站位於四川省甘孜州雅江縣境內,為雅礱江中游龍頭梯級水庫電站,是國家重點清潔能源工程,投產後可極大改善四川電網電源結構,並可助力我國實現“碳達峯、碳中和”戰略目標。電站裝機300萬千瓦,多年平均年發電量110億千瓦時,繼首批兩台機組於2021年9月29日投產發電以來,年內已累計投產發電五台機組,雅礱江中游水電開發穩步推進,公司源源不斷為國家貢獻綠色清潔可再生能源。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.